Pancreatic Cancer Research

ResearcherUniversity of Chicago Medical CenterActive in the last 2 years

Zhenyu Ye

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1850-0436; OpenAlex author ID A5100703518. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 4

  1. Oncolytic vaccinia virus armed with 4-1BBL elicits potent and safe antitumor immunity and enhances the therapeutic efficiency of PD-1/PD-L1 blockade in a pancr… Co-author DOI 10.1016/j.tranon.2024.102151↗
  2. The Anti-Tumor Activity of Afatinib in Pancreatic Ductal Adenocarcinoma Cells. Co-author DOI 10.2174/1871520620666200508090515↗
  3. Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway. Co-author DOI 10.1038/s41598-018-36214-5↗
  4. Genomic analysis of drug resistant pancreatic cancer cell line by combining long non-coding RNA and mRNA expression profling. First author PMID 25755691↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yushi Ju · 1 shared paper, 2024 · strength 0.23
  2. Wei Chen · 1 shared paper, 2024 · strength 0.23
  3. Chungen Xing · 1 shared paper, 2020 · strength 0.10
  4. Wei Chen · 1 shared paper, 2020 · strength 0.10
  5. Yecheng Li · 1 shared paper, 2020 · strength 0.10
  6. Ming Zhou · 1 shared paper, 2015 · strength 0.06
  7. Juncheng Li · 1 shared paper, 2015 · strength 0.06
  8. Bing Peng · 1 shared paper, 2018 · strength 0.06
  9. Bo Huang · 1 shared paper, 2018 · strength 0.06
  10. Tong‐Chuan He · 1 shared paper, 2018 · strength 0.06
  11. Xin Wang · 1 shared paper, 2018 · strength 0.06
  12. Xubao Liu · 1 shared paper, 2018 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.